Visit our exhibition network
April 9–12, 2024 Munich
November 18–20, 2024 Shanghai
April 15–17, 2024 Mumbai
April 2–4, 2025 Ho Chi Minh City
July 8–10, 2025 Johannesburg
Our next fair
analytica has been the world’s leading trade fair for laboratory technology, analysis and biotechnology for five decades.
April 9–12, 2024
Munich
Selected departments
Selected industries
Most read white papers
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.analytica-world.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
Strategic Rationale and Economics of Combination Support Increased Price of $90 per Biosite Share
04-May-2007 - Beckman Coulter, Inc. announced that it has entered into a revised merger agreement with Biosite, Inc. Under the terms of the revised merger agreement, Beckman Coulter will acquire all of Biosite's outstanding common stock in a cash tender offer for $90.00 per share, or approximately $1.67 ...
12-Apr-2007 - Biosite Incorporated announced that its Board of Directors, after consultation with its financial and legal advisors, has determined that the acquisition proposal set forth in the letter received from Inverness Medical Innovations, Inc. on April 4, 2007 is reasonably likely to lead to a superior ...
28-Mar-2007 - A Cornell researcher is working to develop a quick, simple and cheap immune-system test for people in the developing world. It could help HIV/AIDS sufferers in the poorest countries get appropriate treatment to extend their lives, possibly by as much as 10 to 15 years. The work is part of an ...
27-Mar-2007 - Beckman Coulter, Inc. and Biosite(R) Incorporated announced that they have entered into a definitive merger agreement under which Beckman Coulter will acquire all of Biosite's outstanding common stock in a cash tender offer of $85.00 per share, or approximately $1.55 billion on a fully diluted ...
24-Jul-2006 - Beckman Coulter, Inc. has acquired an In Vitro Diagnostics product license to all real-time polymerase chain reaction (PCR) patents and pending patent applications owned or controlled by Roche Diagnostics, a division of F. Hoffmann-La Roche Ltd, Basel, Switzerland. Beckman Coulter will pay Roche ...
28-Apr-2006 - Applera Corporation and Beckman Coulter, Inc. jointly announced that they have established the terms of a settlement to resolve all outstanding legal disputes between the parties regarding claims to certain Beckman Coulter patented capillary electrophoresis technology and PCR instrumentation ...
25-Aug-2005 - In a move that underscores its growing commitment to the market for rapid diagnostic medical test products, Beckman Coulter, Inc. announced that it has entered into a supply relationship with Princeton BioMeditech Corporation (PBM). Under the agreement, PBM will supply a wide range of rapid ...
26-Jan-2005 - Beckman Coulter, Inc. announced that Scott Garrett has been named chief executive officer (CEO) of the corporation, effective February 21, 2005. Garrett, currently president and chief operating officer (COO), succeeds retiring CEO, John P. Wareham. Wareham will continue as chairman of the board ...
15-Dec-2004 - Beckman Coulter, Inc. announced it has entered into a 5-year distribution agreement with pION INC of Woburn, Mass., to deliver a fully validated solution for the automation of in vitro drug permeability measurements. . "This agreement expands Beckman Coulter's drug discovery automation product ...
© 1997-2024 LUMITOS AG, All rights reserved